Page last updated: 2024-08-26

succinyl-coenzyme a and Diabetes Mellitus, Adult-Onset

succinyl-coenzyme a has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abou Farraj, R; Al Batran, R; Chahade, JJ; Chan, JSF; Crawford, PA; Eaton, F; Glover, JNM; Gopal, K; Greenwell, AA; Lee, C; Saed, CT; Tabatabaei Dakhili, SA; Ussher, JR; Velázquez-Martínez, CA; Yang, K	1

Other Studies

1 other study(ies) available for succinyl-coenzyme a and Diabetes Mellitus, Adult-Onset

Article	Year
The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase. Diabetes, 2023, 01-01, Volume: 72, Issue:1 Topics: Animals; Antipsychotic Agents; Coenzyme A-Transferases; Diabetes Mellitus, Type 2; Dopamine; Fluspirilene; Hyperglycemia; Mice; Mice, Obese; Penfluridol; Pimozide; Receptors, Dopamine	2023

Article

Year

The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase.

Diabetes, 2023, 01-01, Volume: 72, Issue:1

Topics: Animals; Antipsychotic Agents; Coenzyme A-Transferases; Diabetes Mellitus, Type 2; Dopamine; Fluspirilene; Hyperglycemia; Mice; Mice, Obese; Penfluridol; Pimozide; Receptors, Dopamine

2023